Insiders · VVOS

VVOS insider transactions

Vivos Therapeutics Inc. (VVOS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for VVOS

• 15d
  SEC Form 3 filed by new insider V-Co Investors 3 Llc

  3 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 23d
  SEC Form 4 filed by Skaff Michael C

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 71d
  New insider Johnson Gregg C claimed ownership of 3,997 shares (SEC Form 3)

  3 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 309d
  New insider Skaff Michael C claimed ownership of 1,342,498 shares (SEC Form 3)

  3 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 514d
  SEC Form 4 filed by Chief Executive Officer Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 514d
  SEC Form 4 filed by Chief Financial Officer Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 666d
  SEC Form 4 filed by Director Thompson Matthew

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 666d
  SEC Form 4 filed by Director Sokolow Leonard J

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 666d
  SEC Form 4 filed by Chief Executive Officer Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 666d
  SEC Form 4 filed by Director Lindsay Mark F.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 666d
  SEC Form 4 filed by Director Green Ralph Elias

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 666d
  SEC Form 4 filed by Director Krammer Anja B

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 666d
  SEC Form 4 filed by Chief Financial Officer Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1040d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1040d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1045d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1214d
  SEC Form 4: Huntsman Ronald Kirk bought $10,000 worth of shares (20,000 units at $0.50), increasing direct ownership by 73% to 47,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1214d
  SEC Form 4 filed by Lindsay Mark F.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1214d
  SEC Form 4 filed by Sokolow Leonard J

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1214d
  SEC Form 4 filed by Krammer Anja B

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1214d
  SEC Form 4 filed by Thompson Matthew

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1214d
  SEC Form 4 filed by Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1214d
  SEC Form 4 filed by Green Ralph Elias

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1422d
  SEC Form 4: Huntsman Ronald Kirk bought $23,560 worth of shares (12,000 units at $1.96), increasing direct ownership by 77% to 27,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1517d
  SEC Form 4 filed by Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1517d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1531d
  SEC Form 5 filed by Huntsman Ronald Kirk

  5 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1676d
  SEC Form 4: Huntsman Ronald Kirk bought $21,550 worth of Common Stock (5,000 units at $4.31), increasing direct ownership by 48% to 15,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1696d
  SEC Form 4 filed by Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1711d
  SEC Form 4: Huntsman Ronald Kirk bought $15,000 worth of Common Stock (5,000 units at $3.00), increasing direct ownership by 91% to 10,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1719d
  SEC Form 4 filed by Singh Gurdev Dave

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1719d
  SEC Form 4 filed by Krammer Anja B

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1719d
  SEC Form 4 filed by Green Ralph Elias

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1719d
  SEC Form 4 filed by Thompson Matthew

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1719d
  SEC Form 4 filed by SOKOLOW LEONARD J

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1719d
  SEC Form 4 filed by Lindsay Mark F.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1761d
  SEC Form 3: Huntsman Ronald Kirk claimed ownership of 1,740,000 units of Common Stock (Amendment)

  3/A - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1796d
  SEC Form 4: Huntsman Ronald Kirk bought $21,520 worth of Common Stock (4,000 units at $5.38), increasing direct ownership by 267% to 5,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1796d
  SEC Form 4: Amman Bradford K. bought $5,290 worth of Common Stock (1,000 units at $5.29), increasing direct ownership by 100% to 2,000 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1865d
  SEC Form 4 filed by K. Bradford Amman

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)